VERFAHREN ZUR VERWENDUNG VON (1S,3S-)-3-AMINO-4-DIFLUORMETHYLENYL-1-CYCLOPENTAN-SÄURECPPMon, August 12th - 6:15 AM 2019
AstraZeneca completes divestment agreement with Atnahs Pharma for established hypertension medicinesPharmaceutical Business ReviewTue, March 3rd - 7:14 PM 2020
Amunix raises $73m in Series A financing led by Omega FundsPharmaceutical Business ReviewThu, March 5th - 7:14 PM 2020
Japan’s Takeda begins development of plasma-derived therapy for COVID-19Pharmaceutical Business ReviewThu, March 5th - 7:14 PM 2020
InMed Pharmaceuticals announces completed enrollment in phase 1 clinical trial of INM-755 CBN Cream in healthy subjectsPharmaceutical Business ReviewWed, March 11th - 8:11 PM 2020
Janssen gets FDA breakthrough therapy status for JNJ-6372 to treat metastatic NSCLCPharmaceutical Business ReviewWed, March 11th - 8:11 PM 2020
Forty Seven, Rocket collaborate on new treatment for Fanconi AnemiaPharmaceutical Business ReviewThu, March 12th - 8:08 PM 2020
Brii Biosciences provides funding to Columbia University for research on COVID-19 and other coronavirusesPharmaceutical Business ReviewThu, March 12th - 8:08 PM 2020
Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiranPharmaceutical Business ReviewThu, March 19th - 8:12 PM 2020
Entos to develop Fusogenix DNA vaccine to prevent COVID-19 infectionsPharmaceutical Business ReviewThu, March 19th - 8:12 PM 2020

Pages